Dolichols are long-chain polyisoprenoid alcohols whose phosphorylated form anchors assembly of the Glc₃Man₉GlcNAc₂ oligosaccharide, the precursor of every N-linked glycan. The carrier sits in endoplasmic reticulum membranes and comes from the same mevalonate pathway that builds isoprenoids and cholesterol.
Lipid Class
Polyisoprenoid alcohol (prenol lipid)
Core Composition
Isoprene units ending in a saturated alpha unit bearing a hydroxyl
Active Form
Dolichol phosphate; cycles to dolichyl pyrophosphate
Congenital disorders of glycosylation; Alzheimer disease; brain aging
Structure & Classification
Chains of varying length, mostly unsaturated, ending in an alpha-saturated isoprenoid unit that carries the alcohol.
Dolichol-20 (C₁₀₀H₁₆₄O, twenty isoprenes) has a molar mass of 1382.37 g/mol.
Bacteria use shorter, non-alpha-saturated polyprenols for cell-wall biosynthesis, not glycosylation.
First published in 1960; the name comes from Ancient Greek dolichos, long.
Biosynthesis & Metabolism
Chains grow in the mevalonate (HMG-CoA reductase) pathway: farnesyl diphosphate condenses with isopentenyl diphosphate into polyprenyl diphosphate, then loses phosphate as dehydrodolichol.
A still-hypothetical alpha-saturase saturates the terminal unit.
Defective assembly of the dolichol-linked Glc₃Man₉GlcNAc₂ precursor, or its transfer to proteins, leaves glycans partly or wholly absent.
It also serves O- and C-mannosylation and glycosylphosphatidylinositol anchor biosynthesis, via dolichyl-P-mannose-type intermediates.
Statins decrease dolichol levels in the body by throttling the shared pathway.
Physiological Role
Dolichol phosphate anchors Glc₃Man₉GlcNAc₂ formation in the rough endoplasmic reticulum and its transfer onto Asn-X-Ser/Thr sequences of newly forming proteins.
The lipid is critical for eukaryotic glycosylation, anchoring single sugars and finished oligosaccharides.
Dolichols are the major lipid component (14% by mass) of human substantia nigra neuromelanin.
Type I glycosylation disorders strike in the endoplasmic reticulum or cytosol where the glycan is assembled; type II defects act later in the Golgi apparatus.
Serum transferrin glycosylation is the routine screening test.
Clinical Relevance
CDG are roughly 200 mostly autosomal recessive disorders of protein and lipid glycosylation.
Dolichol is a proposed aging biomarker: the aging brain shows progressive dolichol increase with reduced ubiquinone.
Alzheimer disease shows the reverse — decreased dolichol, increased ubiquinone — so it is not simply premature aging.